Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02162563
Title Treatment Strategies in Colorectal Cancer Patients With Initially Unresectable Liver-only Metastases (CAIRO5)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Dutch Colorectal Cancer Group
Indications

colorectal cancer

Therapies

Bevacizumab + Fluorouracil + Irinotecan + Leucovorin

Fluorouracil + Irinotecan + Leucovorin + Panitumumab

Bevacizumab + Fluorouracil + Irinotecan + Leucovorin + Oxaliplatin

Fluorouracil + Leucovorin + Oxaliplatin + Panitumumab

Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin

Age Groups: adult | senior
Covered Countries BEL


No variant requirements are available.